Simple Summary Transplant oncology is an evolving treatment ideal for patients suffering
from various cancers with poor prognoses. The concept essentially is the complete removal …

Simple Summary Cholangiocarcinoma is a relatively rare but deadly disease with
traditionally limited treatment options. The disease can be categorized by anatomic location …

Systemic combination therapy of immune checkpoint inhibitors and vascular endothelial
growth factors have provided the basis for improved outcomes in select patients with …

Intrahepatic cholangiocarcinoma (iCCA) is a primary epithelial cell malignancy of the liver
with rising incidence rate globally. Its insidious presentation, heterogeneous and aggressive …

Simple Summary Cholangiocarcinoma constitutes around 3% of gastrointestinal cancers,
and mortality from this cancer has been rising in the recent decades. Many cases of …

Cholangiocarcinoma (CCA) is a hepatic malignancy that has a rapidly increasing incidence.
CCA is anatomically classified into intrahepatic (iCCA) and extrahepatic (eCCA), which is …

Simple Summary Immune checkpoint inhibitors (ICIs) are being increasingly used after
primary treatment of early-stage tumors to treat any residual disease and prevent …

Simple Summary Cholangiocarcinoma (CCA) poses a substantial threat as it ranks as the
second most prevalent primary liver tumor. This review reports comprehensively describe …

Liver transplantation for the management of patients with unresectable iCCA is currently a
reality under strict research protocols. Who is a candidate for transplantation, when to use …

Background Cholangiocarcinoma (CCA), the adenocarcinoma of the biliary duct, is
commonly reported in Asia, with the highest incidence in northeastern Thailand …